Ductal Carcinoma In Situ (DCIS) Treatment in India

Ductal Carcinoma In Situ (DCIS) is the earliest form of breast cancer, confined to the milk ducts and not yet invasive. It is usually detected through routine mammography and has an excellent prognosis when treated promptly. Women diagnosed with DCIS have access to breast-conserving therapies and hormonal treatments to prevent progression. In India, DCIS treatment costs typically range between $3,000 and $7,000, depending on surgery, radiation, and medications, making it highly affordable for international patients.

What Is Ductal Carcinoma In Situ (DCIS)?

Ductal Carcinoma In Situ is a non-invasive breast cancer where abnormal cells are found in the lining of a milk duct but have not spread to surrounding breast tissue. Although it is not life-threatening, DCIS can develop into invasive cancer if left untreated, which is why early management is critical.

How Is DCIS Different from Invasive Breast Cancer?

The term “in situ” means “in place.” In DCIS, cancerous cells are restricted within the ducts and have not invaded nearby tissue or lymph nodes.

Unlike invasive breast cancers, DCIS does not typically form a lump and is most often found through screening mammograms, not physical symptoms.

What Are the Types and Grades of DCIS?

1. Types by Appearance:

50. Comedo DCIS: High-grade cells with dead cells in the center (more aggressive).
50. Non-comedo DCIS: Slower-growing, less aggressive forms.

2. Grading by Aggressiveness:

50. Low-grade: Slow-growing with a lower risk of becoming invasive.
50. Intermediate-grade: Moderate risk; may require more proactive treatment.
50. High-grade: Faster-growing, more likely to become invasive without treatment.

What Causes DCIS and Who Is at Risk?

Several factors may increase the likelihood of developing DCIS:

50. Hormonal factors: Prolonged estrogen exposure.
50. Family history: Especially first-degree relatives with breast cancer.
50. Age: Most cases are diagnosed in women over 50.
50. Genetic mutations: Especially BRCA1 or BRCA2 carriers.
50. Lifestyle factors: Obesity, alcohol use, and lack of physical activity.

What Are the Symptoms of DCIS?

DCIS is usually asymptomatic. Most women do not experience any noticeable changes. It is often discovered during routine screening mammograms, which may show:

Microcalcifications (small calcium deposits) in a clustered pattern.

50. In rare cases, DCIS may cause:
50. Nipple discharge
50. A palpable lump
50. Skin changes or tenderness in the breast

How Is DCIS Diagnosed?

Diagnosis involves a combination of imaging and biopsy:

50. Mammogram: Primary method of detection.
50. Breast Ultrasound or MRI: Used if mammogram is unclear.
50. Core Needle Biopsy: To confirm diagnosis.
50. Surgical (Excisional) Biopsy: To remove suspicious tissue for full analysis.

Does DCIS Have Stages Like Other Cancers?

DCIS is considered Stage 0 breast cancer, meaning it is:

50. Localized within the ductal system
50. Non-invasive
50. At risk for progressing to Stage I or higher if not treated

Though it doesn’t spread like invasive cancers, DCIS requires active treatment to prevent future complications.

What Are the Treatment Options for DCIS?

1. Lumpectomy

Also known as breast-conserving surgery, this involves removing only the cancerous area.

2. Mastectomy

Recommended if DCIS is widespread or in multiple areas of the breast.

3. Radiation Therapy

Typically follows lumpectomy to reduce recurrence risk.

4. Hormonal Therapy

50. Used if the tumor is estrogen receptor-positive (ER+).
50. Tamoxifen or aromatase inhibitors help prevent recurrence or new cancer.

The exact treatment plan is personalized based on tumor grade, patient age, hormone receptor status, and preference.

What Devices Are Used in DCIS Diagnosis and Treatment?

50. Digital Mammography Machines: Detect microcalcifications.
50. Ultrasound & MRI Machines: Assist in further imaging.
50. Stereotactic Biopsy Equipment: Guides biopsy using imaging.
50. Radiation Therapy Equipment: Includes LINAC or IMRT systems.
50. Surgical Tools: For lumpectomy or mastectomy with cosmetic precision.

What Procedures Are Common in DCIS Treatment?

50. Daycare Surgery: Many lumpectomies are done as outpatient procedures.
50. Post-Surgical Radiation: Delivered over 3–5 weeks.
50. Oral Hormonal Therapy: Continued for 5–10 years in hormone-sensitive DCIS.

Why Is Early Treatment of DCIS So Important?

Prompt treatment:

50. Prevents progression to invasive cancer.
50. Allows for less aggressive treatment with fewer side effects.
50. Minimizes psychological stress and future uncertainty.
50. Offers excellent chances of complete remission.

What Are the Advantages of Early DCIS Management?

50. High cure rate with appropriate treatment.
50. Breast conservation options preserve body image.
50. Minimal recovery time with daycare surgery.
50. Reduced need for chemotherapy or long hospital stays.

Why Choose India for DCIS Treatment?

India offers:

50. World-class cancer hospitals with specialized breast units.
50. Experienced oncologists and surgeons.
50. Access to advanced imaging and diagnostics.
50. Affordable care packages without compromising quality.
50. Short waiting periods and international patient coordinators.

Why Choose Dr. Ankur Bahl for DCIS Care?

Dr. Ankur Bahl is one of India’s most respected cancer specialists, known for:

50. Expertise in early-stage breast cancers, including DCIS.
50. Holistic care approach integrating surgery, radiation, and hormonal therapy.
50. Experience treating international patients from diverse backgrounds.
50. A commitment to patient education and empowerment.

What Is the Cost of DCIS Treatment in India?

Compared to the US or UK, India offers up to 70% cost savings with global-standard treatment and facilities.

What Does Follow-Up After DCIS Treatment Involve?

50. Mammogram every 6–12 months to detect recurrence or new tumors.
50. Physical breast exams by a doctor.
50. Monitoring for side effects of radiation or hormonal therapy.
50. Lifestyle advice on diet, stress management, and exercise.

What Is the Prognosis and Recurrence Risk After DCIS Treatment?

50. 5-year survival rate: Nearly 100% when treated properly.
50. Recurrence risk: Around 10–20%, mostly in the same breast.
50. Risk is reduced significantly with radiation and hormonal therapy.
50. New cancers may still develop, so ongoing surveillance is essential

Ductal Carcinoma In Situ (DCIS) is a highly treatable form of early breast cancer when diagnosed promptly. Choosing India for DCIS care gives you access to advanced diagnostic tools, experienced specialists, and affordable treatment plans. With experts like Dr. Ankur Bahl, patients can confidently pursue care that is compassionate, evidence-based, and globally recognized.